This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth (UNH) Extends Plan Coverage in Massachusetts
by Zacks Equity Research
UnitedHealth Group's unit (UNH) provides an integrated health benefit plan in a bid to offer better health outcomes for eligible members in Massachusetts, who qualify for both Medicare and MassHealth.
Humana (HUM) to Provide Value-Based Care in Central Kansas
by Zacks Equity Research
Humana (HUM) expands the value-based agreement with Hutchinson Clinic in a bid to provide enhanced healthcare services to its MA members in central Kansas.
Humana (HUM) Ties Up With Allina Health to Boost Value-Based Care
by Zacks Equity Research
Humana (HUM) expands value-based agreement with Allina Health, which is aimed at offering enhanced outcomes for HUM's MA members in Minnesota.
The Zacks Analyst Blog Highlights: McDonald's, United Parcel Service, Philip Morris, Cigna, Mitsubishi UFJ Financial and Emerson Electric
by Zacks Equity Research
The Zacks Analyst Blog Highlights: McDonald's, United Parcel Service, Philip Morris, Cigna, Mitsubishi UFJ Financial and Emerson Electric
Top Stock Reports for McDonald's, UPS & Philip Morris
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including McDonald's Corporation (MCD), United Parcel Service, Inc. (UPS), and Philip Morris International Inc. (PM).
Select Medical (SEM) Q3 Earnings Beat, Hikes '21 EPS View
by Zacks Equity Research
Select Medical's (SEM) third-quarter results reflect solid revenues driven by strong segmental contributions, and an uptick in admissions and patient visits, partly offset by elevated costs.
Cigna (CI) Q3 Earnings Beat Estimates, Ups '21 EPS View
by Zacks Equity Research
Cigna's (CI) third-quarter results reflect solid segmental performances, consistent expense efficiency and continued medical membership growth.
Cigna (CI) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of 9.56% and 3.15%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Cigna (CI) to Post Earnings in Q3: What's in the Offing?
by Zacks Equity Research
Cigna's (CI) Q3 results are likely to reflect growth in earnings and revenues.
What's in Store for Fidelity National (FNF) in Q3 Earnings?
by Zacks Equity Research
Fidelity National's (FNF) Q3 results is likely to have benefited from strong origination demand and continued rebound in commercial real estate activity in a still-low interest rate environment.
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXH
Cigna (CI) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for Prudential (PRU) This Earnings Season?
by Zacks Equity Research
Prudential's (PRU) Q3 results are likely to reflect solid investment performance, fixed income flows and higher fee income.
What's in Store for Arthur J. Gallagher (AJG) in Q3 Earnings?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) third-quarter results are expected to reflect new business, improved rate, exposure growth and solid retention, growth in core health and welfare fee for service and retirement consulting business.
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Everest Re (RE) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Everest Re's (RE) Q3 results are likely to benefit from rate increases, strong renewal retention, new business, and higher net investment income, offset by higher cat loss.
Aflac (AFL) to Report Q3 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Aflac's (AFL) Q3 results are likely to reflect a decline in earnings as well as revenues.
Chubb (CB) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Chubb (CB) Q3 earnings likely to reflect impact of positive rate increases, exposure growth, strong renewal retention, and growth in new business written partially offset by cat loss.
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
What's in the Cards for W. R. Berkley (WRB) in Q3 Earnings?
by Zacks Equity Research
W. R. Berkley's (WRB) third-quarter results are likely to reflect premium growth and improved expense ratio, partly offset by higher expenses and lower underwriting income.
7 Insurers Poised to Outperform Q3 Earnings Expectation
by Tanuka De
Better pricing, exposure growth, redesigning of products and sturdy capital are expected to help WRB, ATH, MET, PRI, CI, AJG, and AFL outperform Q3 earnings estimates.
The Zacks Analyst Blog Highlights: Edwards Lifesciences, DexCom, Twitter, Cigna Corp and Restaurant Brands
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Edwards Lifesciences, DexCom, Twitter, Cigna Corp and Restaurant Brands
Top Analyst Reports for Edwards Lifesciences, DexCom & Twitter
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including Edwards Lifesciences Corporation (EW), DexCom, Inc. (DXCM), and Twitter, Inc. (TWTR).
Anthem's (ANTM) MA Members to be Covered Under Highly Rated Plans
by Zacks Equity Research
Anthem's (ANTM) 72% Medicare Advantage members to be covered under highly rated plans starting 2022. The ratings reflect the company's commitment to provide better healthcare.
Why the Earnings Surprise Streak Could Continue for Cigna (CI)
by Zacks Equity Research
Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.